Conference
A Phase 2, Randomized, Placebo-Controlled, Multiple Ascending-Dose Study of ACE-031, a Soluble Activin Receptor Type IIB, in Boys with Duchenne Muscular Dystrophy (DMD) (P04.088)
Authors
Campbell C; Escolar D; Mah J; Tarnopolsky M; Selby K; McMillan H; Yang Y; Wilson D; Barger R; Sherman M
Volume
78
Pagination
pp. p04.088-p04.088
Publisher
Wolters Kluwer
Publication Date
April 25, 2012
DOI
10.1212/wnl.78.1_meetingabstracts.p04.088
Conference proceedings
Neurology
Issue
Meeting Abstracts 1
ISSN
0028-3878